These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21737285)

  • 1. Discovery of selective indole-based prostaglandin D₂ receptor antagonist.
    Iwahashi M; Shimabukuro A; Onoda T; Matsunaga Y; Okada Y; Matsumoto R; Nambu F; Nakai H; Toda M
    Bioorg Med Chem; 2011 Aug; 19(15):4574-88. PubMed ID: 21737285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of new orally active prostaglandin D2 receptor antagonists.
    Iwahashi M; Naganawa A; Kinoshita A; Shimabukuro A; Nishiyama T; Ogawa S; Matsunaga Y; Tsukamoto K; Okada Y; Matsumoto R; Nambu F; Oumi R; Odagaki Y; Katagi J; Yano K; Tani K; Nakai H; Toda M
    Bioorg Med Chem; 2011 Nov; 19(22):6935-48. PubMed ID: 21982795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of new chemical leads for prostaglandin D2 receptor antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Egashira H; Nakai Y; Okada Y; Nanbu F; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4557-62. PubMed ID: 15357992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of orally active prostaglandin D2 receptor antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4891-5. PubMed ID: 15341946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Toda M
    Bioorg Med Chem; 2004 Oct; 12(20):5361-78. PubMed ID: 15388164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prostaglandin D2 receptor antagonists based on a tetrahydropyridoindole scaffold.
    Beaulieu C; Guay D; Wang Z; Leblanc Y; Roy P; Dufresne C; Zamboni R; Berthelette C; Day S; Tsou N; Denis D; Greig G; Mathieu MC; O'Neill G
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2696-700. PubMed ID: 18359630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a prostaglandin D2 receptor antagonist: discovery of a new chemical lead.
    Torisu K; Kobayashi K; Iwahashi M; Egashira H; Nakai Y; Okada Y; Nanbu F; Ohuchida S; Nakai H; Toda M
    Eur J Med Chem; 2005 May; 40(5):505-19. PubMed ID: 15893024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azaindoles as potent CRTH2 receptor antagonists.
    Simard D; Leblanc Y; Berthelette C; Zaghdane MH; Molinaro C; Wang Z; Gallant M; Lau S; Thao T; Hamel M; Stocco R; Sawyer N; Sillaots S; Gervais F; Houle R; Lévesque JF
    Bioorg Med Chem Lett; 2011 Jan; 21(2):841-5. PubMed ID: 21185722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.
    Torisu K; Kobayashi K; Iwahashi M; Nakai Y; Onoda T; Nagase T; Sugimoto I; Okada Y; Matsumoto R; Nanbu F; Ohuchida S; Nakai H; Masaaki Toda
    Bioorg Med Chem; 2004 Sep; 12(17):4685-700. PubMed ID: 15358295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indole-3-acetic acid antagonists of the prostaglandin D2 receptor CRTH2.
    Armer RE; Ashton MR; Boyd EA; Brennan CJ; Brookfield FA; Gazi L; Gyles SL; Hay PA; Hunter MG; Middlemiss D; Whittaker M; Xue L; Pettipher R
    J Med Chem; 2005 Oct; 48(20):6174-7. PubMed ID: 16190744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel and potent CRTH2 antagonists.
    Ito S; Terasaka T; Zenkoh T; Matsuda H; Hayashida H; Nagata H; Imamura Y; Kobayashi M; Takeuchi M; Ohta M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1194-7. PubMed ID: 22178554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an indole series of prostaglandin D2 receptor antagonists.
    Sturino CF; Lachance N; Boyd M; Berthelette C; Labelle M; Li L; Roy B; Scheigetz J; Tsou N; Brideau C; Cauchon E; Carriere MC; Denis D; Greig G; Kargman S; Lamontagne S; Mathieu MC; Sawyer N; Slipetz D; O'Neill G; Wang Z; Zamboni R; Metters KM; Young RN
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3043-8. PubMed ID: 16529930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of new prostaglandin D₂ receptor antagonists.
    Iwahashi M; Takahashi E; Tanaka M; Matsunaga Y; Okada Y; Matsumoto R; Nambu F; Nakai H; Toda M
    Bioorg Med Chem; 2011 Sep; 19(18):5361-71. PubMed ID: 21885288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Indolyl sultams as selective CRTh2 antagonists.
    Tumey LN; Robarge MJ; Gleason E; Song J; Murphy SM; Ekema G; Doucette C; Hanniford D; Palmer M; Pawlowski G; Danzig J; Loftus M; Hunady K; Sherf B; Mays RW; Stricker-Krongrad A; Brunden KR; Bennani YL; Harrington JJ
    Bioorg Med Chem Lett; 2010 Jun; 20(11):3287-90. PubMed ID: 20457519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonists.
    Sandham DA; Adcock C; Bala K; Barker L; Brown Z; Dubois G; Budd D; Cox B; Fairhurst RA; Furegati M; Leblanc C; Manini J; Profit R; Reilly J; Stringer R; Schmidt A; Turner KL; Watson SJ; Willis J; Williams G; Wilson C
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4794-8. PubMed ID: 19592244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation.
    Bain G; Lorrain DS; Stebbins KJ; Broadhead AR; Santini AM; Prodanovich P; Darlington J; King CD; Lee C; Baccei C; Stearns B; Troung Y; Hutchinson JH; Prasit P; Evans JF
    J Pharmacol Exp Ther; 2011 Jul; 338(1):290-301. PubMed ID: 21487069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffold.
    Valdenaire A; Pothier J; Renneberg D; Riederer MA; Peter O; Leroy X; Gnerre C; Fretz H
    Bioorg Med Chem Lett; 2013 Feb; 23(4):944-8. PubMed ID: 23324405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro evaluation of a selective antagonist and the corresponding radioligand for the prostaglandin D2 receptor CRTH2.
    Ulven T; Gallen MJ; Nielsen MC; Merten N; Schmidt C; Mohr K; Tränkle C; Kostenis E
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5924-7. PubMed ID: 17845848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981.
    Luker T; Bonnert R; Brough S; Cook AR; Dickinson MR; Dougall I; Logan C; Mohammed RT; Paine S; Sanganee HJ; Sargent C; Schmidt JA; Teague S; Thom S
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6288-92. PubMed ID: 21944852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, pharmacodynamics, and safety of a prostaglandin D2 receptor antagonist.
    Lai E; Wenning LA; Crumley TM; De Lepeleire I; Liu F; de Hoon JN; Van Hecken A; Depré M; Hilliard D; Greenberg H; O'Neill G; Metters K; Gottesdiener KG; Wagner JA
    Clin Pharmacol Ther; 2008 Jun; 83(6):840-7. PubMed ID: 17882161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.